These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2981974)

  • 1. Haemadsorption and haemagglutination by feline leukaemia viruses.
    Mochizuki M; Jarrett O
    J Gen Virol; 1985 Feb; 66 ( Pt 2)():385-9. PubMed ID: 2981974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polypeptides of feline leukaemia virus: identification of p15(E) and p12(E).
    Neil JC; Onions DE; Jarrett O
    J Gen Virol; 1980 Oct; 50(2):455-60. PubMed ID: 6257828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes.
    Rigby MA; Rojko JL; Stewart MA; Kociba GJ; Cheney CM; Rezanka LJ; Mathes LE; Hartke JR; Jarrett O; Neil JC
    J Gen Virol; 1992 Nov; 73 ( Pt 11)():2839-47. PubMed ID: 1331290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel subgroup A variants with enhanced receptor binding and replicative capacity in primary isolates of anaemogenic strains of feline leukaemia virus.
    Stewart H; Adema KW; McMonagle EL; Hosie MJ; Willett BJ
    Retrovirology; 2012 May; 9():48. PubMed ID: 22650160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo infection of marrow stromal fibroblasts by feline leukemia virus.
    Linenberger ML; Abkowitz JL
    Exp Hematol; 1992 Sep; 20(8):1022-7. PubMed ID: 1324184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning and characterization of a defective recombinant feline leukaemia virus associated with myeloid leukaemia.
    Tzavaras T; Stewart M; McDougall A; Fulton R; Testa N; Onions DE; Neil JC
    J Gen Virol; 1990 Feb; 71 ( Pt 2)():343-54. PubMed ID: 2155287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage tropism of feline leukemia virus (FeLV) of subgroup-C and increased production of tumor necrosis factor-alpha by FeLV-infected macrophages.
    Khan KN; Kociba GJ; Wellman ML
    Blood; 1993 May; 81(10):2585-90. PubMed ID: 8387834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feline Pit2 functions as a receptor for subgroup B feline leukemia viruses.
    Anderson MM; Lauring AS; Robertson S; Dirks C; Overbaugh J
    J Virol; 2001 Nov; 75(22):10563-72. PubMed ID: 11602698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic target cells of anemogenic subgroup C versus nonanemogenic subgroup A feline leukemia virus.
    Dean GA; Groshek PM; Mullins JI; Hoover EA
    J Virol; 1992 Sep; 66(9):5561-8. PubMed ID: 1323710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
    Rojko JL; Hoover EA; Finn BL; Olsen RG
    J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The specificity of neutralizing antibodies to feline leukaemia viruses.
    Russell PH; Jarrett O
    Int J Cancer; 1978 Jun; 21(6):768-78. PubMed ID: 208991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal processing of a recombinant feline leukemia virus envelope polyprotein and its interference with subgroup C virus infection.
    Bechtel MK; Stallcup MR; Bedgood RM; Corey JL; Pandey R; Roy-Burman P
    Virology; 1994 Jul; 202(1):329-38. PubMed ID: 8009844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition.
    Boomer S; Eiden M; Burns CC; Overbaugh J
    J Virol; 1997 Nov; 71(11):8116-23. PubMed ID: 9343161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenicity of a subgroup C feline leukemia virus (FeLV) is augmented when administered in association with certain FeLV recombinants.
    Mathes LE; Pandey R; Chakrabarti R; Hofman FM; Hayes KA; Stromberg P; Roy-Burman P
    Virology; 1994 Jan; 198(1):185-95. PubMed ID: 8259654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenicity of feline leukemia virus is commonly associated with variant viruses.
    Jarrett O
    Leukemia; 1992; 6 Suppl 3():153S-154S. PubMed ID: 1318467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against feline leukemia virus infection by use of an inactivated virus vaccine.
    Hoover EA; Perigo NA; Quackenbush SL; Mathiason-DuBard CK; Overbaugh JM; Kloetzer WS; Elder JH; Mullins JI
    J Am Vet Med Assoc; 1991 Nov; 199(10):1392-401. PubMed ID: 1666090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host cell range of T-lymphotropic feline leukemia virus in vitro.
    Shojima T; Nakata R; Miyazawa T
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1466-70. PubMed ID: 16730653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of persistent viraemia and latent feline leukaemia virus infection in cats with lymphoma.
    Stützer B; Simon K; Lutz H; Majzoub M; Hermanns W; Hirschberger J; Sauter-Louis C; Hartmann K
    J Feline Med Surg; 2011 Feb; 13(2):81-7. PubMed ID: 21131219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kinetics of feline leukaemia virus shedding in experimentally infected cats are associated with infection outcome.
    Cattori V; Tandon R; Riond B; Pepin AC; Lutz H; Hofmann-Lehmann R
    Vet Microbiol; 2009 Jan; 133(3):292-6. PubMed ID: 18774240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemagglutination by bovine leukaemia virus.
    Sentsui H; Thorn RM; Kono Y; Ferrer JF
    J Gen Virol; 1982 Mar; 59(Pt 1):83-9. PubMed ID: 6279777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.